The Comparison of High-Dose Heamodiafiltration (HDF) versus Haemodialyse

Project Information

CONVINCE

Grant agreement ID: 754803

DOI

10.3030/754803

Project closed

EC signature date 5 December 2017

Start date 1 January 2018

End date 31 December 2023

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

€ 6 648 605,25

EU contribution

€ 6 440 488,50

Coordinated by

UNIVERSITAIR MEDISCH CENTRUM UTRECHT
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (6)

Project plan with general description of RCT, also including inclusion and exclusion criteria

Project plan with general description of RCT also including inclusion and exclusion criteria

Final set of analyses
Rationale and study paper
Report on baseline characteristics
Final set of analyses (publication)

Final set on analyses

Report on proposed guidelines

Websites, patent fillings, videos etc. (1)

Project logo and website

Publications

Peer reviewed articles (9)

Clinical evidence on haemodiafiltration

Author(s): Peter J Blankestijn, Muriel P Grooteman, Menso J Nube, Michiel L Bots
Published in: Nephrology Dialysis Transplantation, Issue 33/suppl_3, 2018, Page(s) iii53-iii58, ISSN 0931-0509
Publisher: Oxford University Press
DOI: 10.1093/ndt/gfy218

Comparison Between the Physical Performance Test and the Clinical Frailty Score in Adult Patients With Chronic Kidney Disease Treated by Haemodialysis

Author(s): Andrew Davenport
Published in: Gerontology and Geriatric Medicine, Issue 23337214, 2022, ISSN 2333-7214
Publisher: Sage Publishing
DOI: 10.1177/23337214221085875

CONVINCE in the context of existing evidence on haemodiafiltration

Author(s): Vernooij, R.W.M., Bots, M.L., Strippoli, G.F.M., Canaud, B., Cromm, K., Woodward, M., Blankestijn, P.J.
Published in: Nephrology Dialysis Transplantation, Issue 09310509, 2022, Page(s) 1006-1013, ISSN 0931-0509
Publisher: Oxford University Press
DOI: 10.1093/ndt/gfac019

High-Target Hemodiafiltration Convective Dose Achieved in Most Patients in a 6-Month Intermediary Analysis of the CONVINCE Randomized Controlled Trial

Author(s): Robin W.M. Vernooij, C. Hockham, C. Barth, B. Canaud, K. Cromm, A. Davenport, J. Hegbrant, M. Rose, G.F.M. Strippoli, M. Török, M. Woodward, M.L. Bots and P.J. Blankestijn
Published in: Kidney International Reports, Issue Vol 8, Issue 11, 2023, Page(s) 2276-2283, ISSN 2468-0249
Publisher: Elsevier
DOI: 10.1016/j.ekir.2023.08.004

Effect of Hemodiafiltration or Hemodialysis on Mortality in Kidney Failure.

Author(s): Blankestijn PJ, Vernooij RWM, Hockham C, Strippoli G, Canaud B, Hegbrant J, Barth, C, Covic A, Cromm K, Cucui A, Davenport A, Rose M, Török M, Woodward M, Bots ML
Published in: The New England Journal of Medicine, Issue 389, 2023, Page(s) 700-709, ISSN 0028-4793
Publisher: Massachusetts Medical Society
DOI: 10.1056/nejmoa2304820

Controversy on the CONVINCE study findings: the PRO take /Controvérsia sobre os achados do estudo CONVINCE: a perspectiva PRO

Author(s): Peter Blankestijn, Bernard Canaud
Published in: Brazilian Journal of Nephrology, Issue PMID: 38358914, 2024, ISSN 2175-8239
Publisher: Elsevier Editora
DOI: 10.1590/2175-8239-jbn-2024-po01en

Physical Performance tasks were linked to the PROMIS physical function metric in patients undergoing hemodialysis

Author(s): Liegl G, Fischer FH, Woodward M, Török M, Strippoli GFM, Hegbrant J, Davenport A, Cromm K, Canaud B, Bots ML, Blankestijn PJ, Barth C, Fischer KI, Rose M
Published in: Journal of Clinical Epidemiology, Issue Vol159, 7/2023, 2023, Page(s) 128-138, ISSN 0895-4356
Publisher: Elsevier BV
DOI: 10.1016/j.clinepi.2023.04.007

Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol

Author(s): Peter J Blankestijn, Kathrin I Fischer, Claudia Barth, Krister Cromm, Bernard Canaud, Andrew Davenport, Diederick E Grobbee, Jörgen Hegbrant, Kit C Roes, Matthias Rose, Giovanni FM Strippoli, Robin WM Vernooij, Mark Woodward, G Ardine de Wit, Michiel L Bots
Published in: BMJ Open, Issue 10/2, 2020, Page(s) e033228, ISSN 2044-6055
Publisher: BMJ Publishing Group
DOI: 10.1136/bmjopen-2019-033228

Personalizing treatment in end-stage kidney disease: deciding between haemodiafiltration and haemodialysis based on individualized treatment effect prediction

Author(s): Rob C M van Kruijsdijk, Robin W M Vernooij, Michiel L Bots, Sanne A E Peters, Jannick A N Dorresteijn, Frank L J Visseren, Peter J Blankestijn, Thomas P A Debray
Published in: Clinical Kidney Journal, Issue vol.15, no 10, 2022, Page(s) 1924-1931, ISSN 2048-8505
Publisher: Oxford University Press
DOI: 10.1093/ckj/sfac153